ROBERTS EIRY
SEC CIK 1727606 · EDGAR
BoughtSold
Most active insiders at BHC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PAULSON & CO. INC. | 10% | $15.62M | — |
| 2 | Lenar Aimee J. | Pres, US Pharma | — | $258.9K |
| 3 | Lee Frank D. | Dir | — | $132.8K |
| 4 | Carson Seana | EVP, GC | — | $115.0K |
| 5 | LEE STEVEN HYOSIG | SVP, CAO, Ctrl | — | — |
| 6 | GOETTLER MICHAEL | Dir | — | — |
| 7 | ROBERTS EIRY | Dir | — | — |
| 8 | Charhon Jean-Jacques | EVP, CFO | — | — |
| 9 | APPIO THOMAS | CEO, Dir | — | — |
| 10 | KAVANAGH SARAH B | Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-26 19:02 | 2026-05-22 | BHC | Bausch Health Companies Inc. | ROBERTS EIRY | Dir | A - Grant | $0.00 | +45.9K | 45.9K | New | $0 | |
| DM | 2025-02-14 | 2025-02-13+ | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale+OE | $116.44 | -2,218 | 34.3K | -6% | -$258.3K |
| DM | 2025-02-14 | 2025-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | M - OptEx | $0.00 | +4,605 | 35.4K | +15% | $0 |
| D | 2025-02-12 | 2025-02-10 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale+OE | $118.22 | -980 | 33.3K | -3% | -$115.9K |
| D | 2025-02-12 | 2025-02-08 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | M - OptEx | $0.00 | +1,860 | 34.2K | +6% | $0 |
| D | 2025-02-04 | 2025-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale+OE | $152.80 | -1,457 | 32.4K | -4% | -$222.6K |
| D | 2025-02-04 | 2025-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | M - OptEx | $0.00 | +2,769 | 33.8K | +9% | $0 |
| DM | 2024-11-12 | 2024-11-08 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | M - OptEx | $81.67 | +7,345 | 30.1K | +32% | +$599.9K |
| D | 2024-02-15 | 2024-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale | $132.96 | -1,114 | 23.7K | -4% | -$148.1K |
| M | 2024-02-08 | 2024-02-06+ | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale | $138.49 | -2,101 | 22.7K | -8% | -$291.0K |
| 2024-02-02 | 2024-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale | $140.79 | -1,457 | 20.8K | -7% | -$205.1K | |
| 2023-12-27 | 2023-12-22 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale | $126.74 | -10.0K | 19.5K | -34% | -$1.27M | |
| DM | 2023-12-14 | 2023-12-12 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | M - OptEx | $81.05 | +13.9K | 36.5K | +62% | +$1.13M |
| DM | 2023-12-14 | 2023-12-12 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale+OE | $120.30 | -13.9K | 29.5K | -32% | -$1.68M |
| DM | 2023-12-11 | 2023-12-07+ | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale+OE | $120.37 | -77.7K | 29.5K | -72% | -$9.35M |
| DM | 2023-12-11 | 2023-12-07+ | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | M - OptEx | $78.53 | +77.7K | 68.2K | New | +$6.10M |
| D | 2023-12-08 | 2023-12-06 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale+OE | $120.03 | -8,396 | 29.5K | -22% | -$1.01M |
| D | 2023-12-08 | 2023-12-06 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | M - OptEx | $77.81 | +8,396 | 37.9K | +28% | +$653.3K |
| 2023-08-23 | 2023-08-21 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale | $107.38 | -3,198 | 29.5K | -10% | -$343.4K | |
| 2023-04-26 | 2023-04-24 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale | $103.48 | -14.4K | 26.6K | -35% | -$1.49M | |
| M | 2023-02-08 | 2023-02-06+ | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale | $102.74 | -16.5K | 40.1K | -29% | -$1.70M |
| 2023-02-02 | 2023-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale | $109.99 | -1,457 | 26.2K | -5% | -$160.3K | |
| M | 2022-02-09 | 2022-02-07+ | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale | $80.45 | -3,724 | 23.7K | -14% | -$299.6K |
| 2022-01-12 | 2022-01-10 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Off | S - Sale | $74.50 | -2,632 | 21.3K | -11% | -$196.1K |
Purchase Sale Sale after option exercise All abbreviations